| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| Cost of Revenue | $253K | — | +0.0% |
| R&D Expense | $2.7M | — | -25.1% |
| SG&A Expense | $2.5M | — | -29.4% |
| Operating Income | -$5.2M | — | +29.7% |
| Net Income | -$7.0M | — | +9.3% |
| EPS (Basic) | -$0.31 | — | +38.0% |
| EPS (Diluted) | -$0.31 | — | +39.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.9M | -24.5% | -0.4% |
| Inventory | $1.6M | -4.1% | -30.6% |
| Current Assets | $15.9M | -21.0% | -8.7% |
| Total Assets | $39.3M | -9.1% | -4.9% |
| Current Liabilities | $8.6M | +4.1% | +42.7% |
| Long-term Debt | $22.9M | +8.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.1M | — | +42.8% |
| Capital Expenditures | $2K | — | -99.4% |
| Investing Cash Flow | -$2K | — | +99.4% |
| Free Cash Flow | -$4.1M | — | +45.3% |
| +29.6% |
| Total Liabilities | $33.6M | +8.9% | +16.0% |
| Stockholders' Equity | $5.7M | -53.8% | -53.8% |